Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Gamme d'année
1.
Braz J Med Biol Res ; 40(3): 305-7, 2007 Mar.
Article de Anglais | MEDLINE | ID: mdl-17334526

RÉSUMÉ

Disorders of the lipid metabolism may play a role in the genesis of abdominal aorta aneurysm. The present study examined the intravascular catabolism of chylomicrons, the lipoproteins that carry the dietary lipids absorbed by the intestine in the circulation in patients with abdominal aorta aneurysm. Thirteen male patients (72 +/- 5 years) with abdominal aorta aneurysm with normal plasma lipid profile and 13 healthy male control subjects (73 +/- 5 years) participated in the study. The method of chylomicron-like emulsions was used to evaluate this metabolism. The emulsion labeled with 14C-cholesteryl oleate and (3)H-triolein was injected intravenously in both groups. Blood samples were taken at regular intervals over 60 min to determine the decay curves. The fractional clearance rate (FCR) of the radioactive labels was calculated by compartmental analysis. The FCR of the emulsion with (3)H-triolein was smaller in the aortic aneurysm patients than in controls (0.025 +/- 0.017 vs 0.039 +/- 0.019 min-1; P < 0.05), but the FCR of 14C-cholesteryl oleate of both groups did not differ. In conclusion, as indicated by the triglyceride FCR, chylomicron lipolysis is diminished in male patients with aortic aneurysm, whereas the remnant removal which is traced by the cholesteryl oleate FCR is not altered. The results suggest that defects in the chylomicron metabolism may represent a risk factor for development of abdominal aortic aneurysm.


Sujet(s)
Anévrysme de l'aorte abdominale/métabolisme , Cholestérol ester/pharmacocinétique , Chylomicron/pharmacocinétique , Lipolyse , Trioléine/pharmacocinétique , Sujet âgé , Anévrysme de l'aorte abdominale/sang , Anévrysme de l'aorte abdominale/étiologie , Indice de masse corporelle , Radio-isotopes du carbone , Études cas-témoins , Cholestérol ester/administration et posologie , Chylomicron/administration et posologie , Émulsions , Humains , Injections veineuses , Mâle , Taux de clairance métabolique , Trioléine/administration et posologie
2.
Braz. j. med. biol. res ; 40(3): 305-307, Mar. 2007.
Article de Anglais | LILACS | ID: lil-441770

RÉSUMÉ

Disorders of the lipid metabolism may play a role in the genesis of abdominal aorta aneurysm. The present study examined the intravascular catabolism of chylomicrons, the lipoproteins that carry the dietary lipids absorbed by the intestine in the circulation in patients with abdominal aorta aneurysm. Thirteen male patients (72 ± 5 years) with abdominal aorta aneurysm with normal plasma lipid profile and 13 healthy male control subjects (73 ± 5 years) participated in the study. The method of chylomicron-like emulsions was used to evaluate this metabolism. The emulsion labeled with 14C-cholesteryl oleate and ³H-triolein was injected intravenously in both groups. Blood samples were taken at regular intervals over 60 min to determine the decay curves. The fractional clearance rate (FCR) of the radioactive labels was calculated by compartmental analysis. The FCR of the emulsion with ³H-triolein was smaller in the aortic aneurysm patients than in controls (0.025 ± 0.017 vs 0.039 ± 0.019 min-1; P < 0.05), but the FCR of14C-cholesteryl oleate of both groups did not differ. In conclusion, as indicated by the triglyceride FCR, chylomicron lipolysis is diminished in male patients with aortic aneurysm, whereas the remnant removal which is traced by the cholesteryl oleate FCR is not altered. The results suggest that defects in the chylomicron metabolism may represent a risk factor for development of abdominal aortic aneurysm.


Sujet(s)
Humains , Mâle , Sujet âgé , Anévrysme de l'aorte abdominale/métabolisme , Cholestérol ester/pharmacocinétique , Chylomicron/pharmacologie , Lipolyse , Trioléine/pharmacocinétique , Anévrysme de l'aorte abdominale/sang , Indice de masse corporelle , Radio-isotopes du carbone , Études cas-témoins , Cholestérol ester/administration et posologie , Chylomicron/administration et posologie , Émulsions , Injections veineuses , Taux de clairance métabolique , Trioléine/administration et posologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...